Class information for:
Level 1: ENFUVIRTIDE//GP41//T 20

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10399 1001 42.4 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
40 31853 AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENFUVIRTIDE Author keyword 97 67% 9% 88
2 GP41 Author keyword 60 39% 12% 122
3 T 20 Author keyword 52 80% 3% 32
4 FUSION INHIBITOR Author keyword 50 60% 5% 55
5 FUSION INHIBITORS Author keyword 21 48% 3% 32
6 SIX HELIX BUNDLE Author keyword 20 63% 2% 20
7 HIV FUSION INHIBITOR Author keyword 15 68% 1% 13
8 HIV 1 FUSION INHIBITOR Author keyword 15 88% 1% 7
9 LINDSLEY F KIMBALL Address 12 14% 8% 79
10 BMS 378806 Author keyword 11 100% 1% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ENFUVIRTIDE 97 67% 9% 88 Search ENFUVIRTIDE Search ENFUVIRTIDE
2 GP41 60 39% 12% 122 Search GP41 Search GP41
3 T 20 52 80% 3% 32 Search T+20 Search T+20
4 FUSION INHIBITOR 50 60% 5% 55 Search FUSION+INHIBITOR Search FUSION+INHIBITOR
5 FUSION INHIBITORS 21 48% 3% 32 Search FUSION+INHIBITORS Search FUSION+INHIBITORS
6 SIX HELIX BUNDLE 20 63% 2% 20 Search SIX+HELIX+BUNDLE Search SIX+HELIX+BUNDLE
7 HIV FUSION INHIBITOR 15 68% 1% 13 Search HIV+FUSION+INHIBITOR Search HIV+FUSION+INHIBITOR
8 HIV 1 FUSION INHIBITOR 15 88% 1% 7 Search HIV+1+FUSION+INHIBITOR Search HIV+1+FUSION+INHIBITOR
9 BMS 378806 11 100% 1% 6 Search BMS+378806 Search BMS+378806
10 HIV 1 FUSION INHIBITORS 11 100% 1% 6 Search HIV+1+FUSION+INHIBITORS Search HIV+1+FUSION+INHIBITORS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FUSION INHIBITOR 81 57% 10% 96
2 ENTRY INHIBITORS 75 39% 15% 149
3 ENFUVIRTIDE 72 52% 10% 99
4 T 20 68 62% 7% 71
5 6 HELIX BUNDLE FORMATION 61 86% 3% 31
6 TYPE 1 GP41 55 58% 6% 62
7 SIV GP41 47 62% 5% 48
8 BMS 378806 45 94% 2% 16
9 TRIMERIC COILED COIL 41 81% 2% 25
10 MULTIFUNCTIONAL DOMAINS 38 93% 1% 14

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Peptides in the treatment of AIDS 2009 47 50 88%
Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes 2004 215 39 64%
Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket 2013 10 87 80%
Development of Peptide and Small-Molecule HIV-1 Fusion Inhibitors that Target gp41 2010 31 96 79%
HIV entry inhibitors targeting gp41: From polypeptides to small-molecule compounds 2007 59 120 63%
Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806 2014 3 45 69%
Inhibition of HIV-1 by Fusion Inhibitors 2010 33 165 61%
HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics 2010 19 80 88%
Resistance to enfuvirtide, the first HIV fusion inhibitor 2004 139 73 52%
Multifaceted action of Fuzeon as virus-cell membrane fusion inhibitor 2011 15 84 62%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LINDSLEY F KIMBALL 12 14% 7.9% 79
2 TROP DIS CONTROL MOE 3 100% 0.3% 3
3 VIRUS CONTROL 2 19% 1.1% 11
4 ABD SEROTEC 2 67% 0.2% 2
5 BIOLCAMBRIDGE 9 1 50% 0.2% 2
6 BIOMODULATORS DRUGS 1 100% 0.2% 2
7 HUMAN VIROLMINIST EDUC 1 100% 0.2% 2
8 OFF VACCINES 1 50% 0.2% 2
9 PEPTIDE EXCELLENCE 1 50% 0.2% 2
10 QUEST CLIN 1 50% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000197345 IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER
2 0.0000148338 CCR5//MARAVIROC//CCR5 ANTAGONIST
3 0.0000145338 FUSION PEPTIDE//MEMBRANE FUSION//VIRAL FUSION PEPTIDE
4 0.0000096674 HIV 1 GP41//GP120 CD4 INTERACTION//CD4 RECEPTOR
5 0.0000068834 CYANOVIRIN N//CV N//ACTINOHIVIN
6 0.0000065526 UF SIDA//KODECYTE//ESA CNRS 6033
7 0.0000065235 VIRUS CELL INTERACT SECT//GAG//M PMV
8 0.0000058565 V PROTEIN//SENDAI VIRUS//PARAMYXOVIRUS
9 0.0000050951 EMI U 9922//UNITE PHYSIOPATHOL INFECT LENTIVIRALES//DIPARTIMENTO IGIENE MED PREVENT SANITA PUBBL
10 0.0000047170 PROTEOMIMETICS//ALPHA HELIX MIMETICS//HELIX MIMETICS